Shares of Burger King were in huge demand for third day in a row after a stellar market debut on Monday. Burger King stock price rose by its daily maximum limit of 10 per cent to hit an intraday high of ₹ 219.15 on the BSE. Burger King’s three-day share sale via Initial Public Offering (IPO), which was open between December 2 and 4, was subscribed 157 times, receiving bids exceeding 1,100 crore compared with 7.45 crore shares on offer. The portion reserved for retail investors was subscribed over 30 times, the qualified institutional buyers (QIB) segment was subscribed 24 times and non-institutional investors (NII) category received subscription of 262 times.
Burger King shares have surged over three times from the issue price of ₹ 60 within three days of listing. The shares of the quick-service restaurant chain listed at ₹ 115.35 on the BSE, a 92.25 per cent premium over the issue price of ₹ 60. On the NSE, the shares debuted at ₹ 112.50, up 87.5 per cent.
Among other stellar listings in the recent past, Chemcon Speciality had surged 115 per cent and Happiest Minds Technologies had rallied 111 per cent on Day 1.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022